Vertosa is a technology company.
Vertosa has raised $6.0M across 1 funding round.
Vertosa has raised $6.0M in total across 1 funding round.
Vertosa has raised $6.0M in total across 1 funding round.
Vertosa's investors include Founders Future, Clement Benoit, Romain Afflelou.
Vertosa is a technology company specializing in emulsion technology for cannabis and hemp-infused products, creating water-compatible active ingredients like nano- and micro-emulsions that enhance bioavailability, stability, and consistency.[1][2][3][5] It serves over 150 brands across North America in sectors such as food, beverages, health, beauty, and gummies, solving challenges like poor solubility, inconsistent potency, separation, and unappealing taste in infused products.[1][3][5][6] The company's growth momentum includes a 2018 founding (formerly Nanogen Labs), a rebrand to Vertosa, expanded operations with new hires for scalability, and proven compatibility with manufacturing processes, packaging (e.g., glass, TetraPak), and pasteurization, positioning it as a leader in scalable infusion solutions.[1][2][3]
Vertosa was founded in 2018 by Harold Han, Ph.D., an emulsion chemist, as Nanogen Labs Inc. in Walnut Creek, California (with early operations noted in Oakland).[1][3][4] Han's expertise in emulsion science drove the idea to develop patent-pending nano- and micro-emulsions that make cannabinoids water-soluble, addressing key barriers in cannabis infusion like bioavailability and stability.[2][3][4] Early traction came from building direct relationships with clients, pioneering shelf-stable infused beverages, and a pivotal rebrand to Vertosa, which reflected its scientific expertise and growth ambitions, including team expansions for operations and market scaling.[1][3]
Vertosa rides the wave of cannabis and hemp legalization, mainstreaming plant medicine through science-backed delivery systems that enable consumer-friendly products like stable, great-tasting infused beverages and edibles.[3][4][5] Timing aligns with growing demand for high-bioavailability wellness products amid market forces like regulatory progress, consumer shift from smoking/vaping, and expansion into nutraceuticals, beauty, and food/beverage.[1][3] It influences the ecosystem by empowering 150+ brands to scale safely, pioneering categories like shelf-stable infusions, and partnering with leaders like TetraPak, thus accelerating cannabis's integration into everyday goods.[2][3][6]
Vertosa is poised to expand beyond beverages into gummies, topicals, and global markets, leveraging ongoing innovations in machinery and trends to "infuse the world" with reliable cannabinoid delivery.[2][5] Rising hemp/cannabis adoption, bioavailability demands, and supply chain sophistication will shape its path, potentially amplifying influence through more patents and partnerships.[3][4] As the science-first enabler of stigma-free plant medicine, Vertosa's emulsions will remain central to unlocking scalable, consumer-predictable experiences in a maturing industry.[4][6]
Vertosa has raised $6.0M across 1 funding round. Most recently, it raised $6.0M Seed in December 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2019 | $6.0M Seed | Founders Future, Clement Benoit, Romain Afflelou |